{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T16:29:01Z","timestamp":1793896141617,"version":"4.8.0"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-58074-0","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T01:41:32Z","timestamp":1742607692000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Smoking aggravates neovascular age-related macular degeneration via Sema4D-PlexinB1 axis-mediated activation of pericytes"],"prefix":"10.1038","volume":"16","author":[{"given":"Kai","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianjing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3392-1362","authenticated-orcid":false,"given":"Yuming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selena","family":"Wei-Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parhat","family":"Kaysar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueming","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4000-931X","authenticated-orcid":false,"given":"Heping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6769-847X","authenticated-orcid":false,"given":"Jun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6621-0591","authenticated-orcid":false,"given":"Qiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0699-1119","authenticated-orcid":false,"given":"Junhao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8628-243X","authenticated-orcid":false,"given":"Xiaohong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7651-840X","authenticated-orcid":false,"given":"Hua","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,22]]},"reference":[{"key":"58074_CR1","doi-asserted-by":"publisher","first-page":"E106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong, W. L. et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob. Health 2, E106\u2013E116 (2014).","journal-title":"Lancet Glob. Health"},{"key":"58074_CR2","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1001\/archophthalmol.2009.58","volume":"127","author":"DB Rein","year":"2009","unstructured":"Rein, D. B. et al. Forecasting age-related macular degeneration through the year 2050 the potential impact of new treatments. Arch. Ophthalmol. 127, 533\u2013540 (2009).","journal-title":"Arch. Ophthalmol."},{"key":"58074_CR3","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/S0140-6736(08)61759-6","volume":"372","author":"HR Coleman","year":"2008","unstructured":"Coleman, H. R., Chan, C. C., Ferris, F. L. 3rd & Chew, E. Y. Age-related macular degeneration. Lancet 372, 1835\u20131845 (2008).","journal-title":"Lancet"},{"key":"58074_CR4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.ophtha.2004.10.047","volume":"112","author":"TE Clemons","year":"2005","unstructured":"Clemons, T. E., Milton, R. C., Klein, R., Seddon, J. M. & Ferris, F. L. 3rd Risk factors for the incidence of advanced age-related macular degeneration in the age-related eye disease study (AREDS) AREDS report no. 19. Ophthalmology 112, 533\u2013539 (2005).","journal-title":"Ophthalmology"},{"key":"58074_CR5","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abj2177","volume":"14","author":"S Yang","year":"2022","unstructured":"Yang, S. et al. Targeting C3b\/C4b and VEGF with a bispecific fusion protein optimized for neovascular age-related macular degeneration therapy. Sci. Transl. Med. 14, eabj2177 (2022).","journal-title":"Sci. Transl. Med."},{"key":"58074_CR6","doi-asserted-by":"publisher","unstructured":"Mettu P. S., Allingham M. J., Cousins S. W. Incomplete response to Anti-VEGF therapy in neovascular AMD: Exploring disease mechanisms and therapeutic opportunities. Prog. Retin. Eye Res. 82, https:\/\/doi.org\/10.1016\/j.preteyeres.2020.100906 (2021).","DOI":"10.1016\/j.preteyeres.2020.100906"},{"key":"58074_CR7","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1167\/iovs.11-8497","volume":"53","author":"JF Menger","year":"2012","unstructured":"Menger, J. F., Haubitz, I. & Keilhauer-Strachwitz, C. N. Influence Of AMD-Risk factors on the effectiveness of anti-VEGF therapy in neovascular age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 53, 857\u2013857 (2012).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"58074_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.tcb.2023.06.001","volume":"34","author":"H van Splunder","year":"2024","unstructured":"van Splunder, H., Villacampa, P., Mart\u00ednez-Romero, A. & Graupera, M. Pericytes in the disease spotlight. Trends Cell Biol. 34, 58\u201371 (2024).","journal-title":"Trends Cell Biol."},{"key":"58074_CR9","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature09522","volume":"468","author":"A Armulik","year":"2010","unstructured":"Armulik, A. et al. Pericytes regulate the blood-brain barrier. Nature 468, 557\u2013561 (2010).","journal-title":"Nature"},{"key":"58074_CR10","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S0002-9440(10)64920-6","volume":"160","author":"S Morikawa","year":"2002","unstructured":"Morikawa, S. et al. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am. J. Pathol. 160, 985\u20131000 (2002).","journal-title":"Am. J. Pathol."},{"key":"58074_CR11","doi-asserted-by":"crossref","unstructured":"van Splunder H., Villacampa P., Martinez-Romero A., Graupera M. Pericytes in the disease spotlight. Trends Cell Biol. 34, 58\u201371 (2023).","DOI":"10.1016\/j.tcb.2023.06.001"},{"key":"58074_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1172\/JCI5028","volume":"103","author":"LE Benjamin","year":"1999","unstructured":"Benjamin, L. E., Golijanin, D., Itin, A., Pode, D. & Keshet, E. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J. Clin. Invest. 103, 159\u2013165 (1999).","journal-title":"J. Clin. Invest."},{"key":"58074_CR13","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00018-008-8518-z","volume":"66","author":"L Roth","year":"2009","unstructured":"Roth, L. et al. The many faces of semaphorins: from development to pathology. Cell. Mol. Life Sci. 66, 649\u2013666 (2009).","journal-title":"Cell. Mol. Life Sci."},{"key":"58074_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nrd4337","volume":"13","author":"T Worzfeld","year":"2014","unstructured":"Worzfeld, T. & Offermanns, S. Semaphorins and plexins as therapeutic targets. Nat. Rev. Drug Discov. 13, 603\u2013621 (2014).","journal-title":"Nat. Rev. Drug Discov."},{"key":"58074_CR15","doi-asserted-by":"publisher","first-page":"4341","DOI":"10.4049\/jimmunol.166.7.4341","volume":"166","author":"A Elhabazi","year":"2001","unstructured":"Elhabazi, A., Delaire, S., Bensussan, A., Boumsell, L. & Bismuth, G. Biological activity of soluble CD100. I. The extracellular region of CD100 is released from the surface of T lymphocytes by regulated proteolysis. J. Immunol. 166, 4341\u20134347 (2001).","journal-title":"J. Immunol."},{"key":"58074_CR16","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1038\/nprot.2013.135","volume":"8","author":"V Lambert","year":"2013","unstructured":"Lambert, V. et al. Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice. Nat. Protocols 8, 2197\u20132211 (2013).","journal-title":"Nat. Protocols"},{"key":"58074_CR17","doi-asserted-by":"publisher","unstructured":"Tomita, Y. et al. An ex vivo choroid sprouting assay of ocular microvascular angiogenesis. J. Vis. Exp. 162, https:\/\/doi.org\/10.3791\/61677 (2020).","DOI":"10.3791\/61677"},{"key":"58074_CR18","doi-asserted-by":"publisher","first-page":"24100","DOI":"10.1073\/pnas.1914143116","volume":"116","author":"AP Voigt","year":"2019","unstructured":"Voigt, A. P. et al. Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration. Proc. Natl. Acad. Sci. USA 116, 24100\u201324107 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"58074_CR19","doi-asserted-by":"publisher","first-page":"11780","DOI":"10.1073\/pnas.93.21.11780","volume":"93","author":"KT Hall","year":"1996","unstructured":"Hall, K. T. et al. Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation. Proc. Natl. Acad. Sci. USA 93, 11780\u201311785 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"58074_CR20","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adi6626","volume":"16","author":"X Dong","year":"2024","unstructured":"Dong, X. et al. Natural killer cells promote neutrophil extracellular traps and restrain macular degeneration in mice. Sci. Transl. Med. 16, eadi6626 (2024).","journal-title":"Sci. Transl. Med."},{"key":"58074_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ni1553","volume":"9","author":"K Suzuki","year":"2008","unstructured":"Suzuki, K., Kumanogoh, A. & Kikutani, H. Semaphorins and their receptors in immune cell interactions. Nat. Immunol. 9, 17\u201323 (2008).","journal-title":"Nat. Immunol."},{"key":"58074_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/978-1-4939-9686-5_3","volume":"2040","author":"M L\u00f3pez-Cano","year":"2019","unstructured":"L\u00f3pez-Cano, M., Fern\u00e1ndez-Due\u00f1as, V. & Ciruela, F. Proximity ligation assay image analysis protocol: Addressing receptor-receptor interactions. Methods Mol. Biol. 2040, 41\u201350 (2019).","journal-title":"Methods Mol. Biol."},{"key":"58074_CR23","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1161\/CIRCRESAHA.120.317025","volume":"127","author":"JT Brash","year":"2020","unstructured":"Brash, J. T. et al. Tamoxifen-activated CreERT impairs retinal angiogenesis independently of gene deletion. Circ. Res. 127, 849\u2013850 (2020).","journal-title":"Circ. Res."},{"key":"58074_CR24","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/s44161-022-00125-6","volume":"1","author":"VS Rashbrook","year":"2022","unstructured":"Rashbrook, V. S., Brash, J. T. & Ruhrberg, C. Cre toxicity in mouse models of cardiovascular physiology and disease. Nat. Cardiovasc. Res. 1, 806\u2013816 (2022).","journal-title":"Nat. Cardiovasc. Res."},{"key":"58074_CR25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.devcel.2011.07.001","volume":"21","author":"A Armulik","year":"2011","unstructured":"Armulik, A., Genov\u00e9, G. & Betsholtz, C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev. Cell 21, 193\u2013215 (2011).","journal-title":"Dev. Cell"},{"key":"58074_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2022.151253","volume":"101","author":"Q Zhang","year":"2022","unstructured":"Zhang, Q. et al. Collagen gel contraction assays: From modelling wound healing to quantifying cellular interactions with three-dimensional extracellular matrices. Eur. J. Cell Biol. 101, 151253 (2022).","journal-title":"Eur. J. Cell Biol."},{"key":"58074_CR27","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1161\/ATVBAHA.107.161521","volume":"29","author":"K Gaengel","year":"2009","unstructured":"Gaengel, K., Genov\u00e9, G., Armulik, A. & Betsholtz, C. Endothelial-mural cell signaling in vascular development and angiogenesis. Arterioscler. Thromb. Vas. Biol. 29, 630\u2013638 (2009).","journal-title":"Arterioscler. Thromb. Vas. Biol."},{"key":"58074_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26259-y","volume":"12","author":"YM Meng","year":"2021","unstructured":"Meng, Y. M. et al. Hexokinase 2-driven glycolysis in pericytes activates their contractility leading to tumor blood vessel abnormalities. Nat. Commun. 12, 6011 (2021).","journal-title":"Nat. Commun."},{"key":"58074_CR29","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/nprot.2017.018","volume":"12","author":"MB Chen","year":"2017","unstructured":"Chen, M. B. et al. On-chip human microvasculature assay for visualization and quantification of tumor cell extravasation dynamics. Nat. Protocols 12, 865\u2013880 (2017).","journal-title":"Nat. Protocols"},{"key":"58074_CR30","doi-asserted-by":"publisher","first-page":"12085","DOI":"10.1073\/pnas.142433199","volume":"99","author":"J Aurandt","year":"2002","unstructured":"Aurandt, J., Vikis, H. G., Gutkind, J. S., Ahn, N. & Guan, K. L. The semaphorin receptor plexin-B1 signals through a direct interaction with the Rho-specific nucleotide exchange factor, LARG. Proc. Natl. Acad. Sci. USA. 99, 12085\u201312090 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"58074_CR31","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0014-5793(02)03323-9","volume":"529","author":"MH Driessens","year":"2002","unstructured":"Driessens, M. H., Olivo, C., Nagata, K., Inagaki, M. & Collard, J. G. B plexins activate Rho through PDZ-RhoGEF. FEBS Lett. 529, 168\u2013172 (2002).","journal-title":"FEBS Lett."},{"key":"58074_CR32","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0006-291X(02)02122-8","volume":"297","author":"M Hirotani","year":"2002","unstructured":"Hirotani, M. et al. Interaction of plexin-B1 with PDZ domain-containing Rho guanine nucleotide exchange factors. Biochem. Biophys. Res. Commun. 297, 32\u201337 (2002).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"58074_CR33","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1083\/jcb.200312094","volume":"165","author":"JM Swiercz","year":"2004","unstructured":"Swiercz, J. M., Kuner, R. & Offermanns, S. Plexin-B1\/RhoGEF-mediated RhoA activation involves the receptor tyrosine kinase ErbB-2. J. Cell Biol. 165, 869\u2013880 (2004).","journal-title":"J. Cell Biol."},{"key":"58074_CR34","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/ncb843","volume":"4","author":"S Giordano","year":"2002","unstructured":"Giordano, S. et al. The semaphorin 4D receptor controls invasive growth by coupling with Met. Nat. Cell Biol. 4, 720\u2013724 (2002).","journal-title":"Nat. Cell Biol."},{"key":"58074_CR35","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1038\/nm.2489","volume":"17","author":"T Negishi-Koga","year":"2011","unstructured":"Negishi-Koga, T. et al. Suppression of bone formation by osteoclastic expression of semaphorin 4D. Nat. Med. 17, 1473\u20131480 (2011).","journal-title":"Nat. Med."},{"key":"58074_CR36","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1084\/jem.184.3.1101","volume":"184","author":"CC Bleul","year":"1996","unstructured":"Bleul, C. C., Fuhlbrigge, R. C., Casasnovas, J. M., Aiuti, A. & Springer, T. A. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J. Exp. Med. 184, 1101\u20131109 (1996).","journal-title":"J. Exp. Med."},{"key":"58074_CR37","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/31269","volume":"393","author":"YR Zou","year":"1998","unstructured":"Zou, Y. R., Kottmann, A. H., Kuroda, M., Taniuchi, I. & Littman, D. R. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393, 595\u2013599 (1998).","journal-title":"Nature"},{"key":"58074_CR38","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.yjmcc.2022.05.002","volume":"169","author":"Q Ma","year":"2022","unstructured":"Ma, Q. et al. CXCR4 blockade in macrophage promotes angiogenesis in ischemic hindlimb by modulating autophagy. J. Mol. Cell.Cardiol. 169, 57\u201370 (2022).","journal-title":"J. Mol. Cell.Cardiol."},{"key":"58074_CR39","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1084\/jem.20161645","volume":"214","author":"Y Sun","year":"2017","unstructured":"Sun, Y. et al. Inflammatory signals from photoreceptor modulate pathological retinal angiogenesis via c-Fos. J. Exp. Med. 214, 1753\u20131767 (2017).","journal-title":"J. Exp. Med."},{"key":"58074_CR40","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.cell.2020.02.028","volume":"180","author":"RS Apte","year":"2020","unstructured":"Apte, R. S. Reducing treatment burden in AMD. Cell 180, 1033 (2020).","journal-title":"Cell"},{"key":"58074_CR41","doi-asserted-by":"publisher","first-page":"3830","DOI":"10.1167\/iovs.12-10341","volume":"54","author":"S Nakao","year":"2013","unstructured":"Nakao, S. et al. Lack of lymphatics and lymph node-mediated immunity in choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 54, 3830\u20133836 (2013).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"58074_CR42","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.1111\/ajt.16760","volume":"21","author":"J Bian","year":"2021","unstructured":"Bian, J. et al. Targeting NF-\u03baB c-Rel in regulatory T cells to treat corneal transplantation rejection. Am. J. Transplant. 21, 3858\u20133870 (2021).","journal-title":"Am. J. Transplant."},{"key":"58074_CR43","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/eye.1997.137","volume":"11","author":"JP Sarks","year":"1997","unstructured":"Sarks, J. P., Sarks, S. H. & Killingsworth, M. C. Morphology of early choroidal neovascularisation in age-related macular degeneration: correlation with activity. Eye 11, 515\u2013522 (1997).","journal-title":"Eye"},{"key":"58074_CR44","doi-asserted-by":"publisher","unstructured":"Luo, X. et al. Choroidal pericytes promote subretinal fibrosis after experimental photocoagulation. Dis. Model Mech. 11, https:\/\/doi.org\/10.1242\/dmm.032060 (2018).","DOI":"10.1242\/dmm.032060"},{"key":"58074_CR45","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.cell.2020.02.003","volume":"181","author":"PP Wong","year":"2020","unstructured":"Wong, P. P. et al. Cancer burden is controlled by mural cell-beta3-integrin regulated Crosstalk with Tumor Cells. Cell 181, 1346\u20131363 (2020).","journal-title":"Cell"},{"key":"58074_CR46","doi-asserted-by":"crossref","unstructured":"Huang, C. et al. Pericytes modulate third-generation tyrosine kinase inhibitor sensitivity in EGFR-mutated lung cancer cells through IL32-\u03b25-integrin paracrine signaling. Adv. Sci. 11, e2405130 (2024).","DOI":"10.1002\/advs.202405130"},{"key":"58074_CR47","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1074\/jbc.M706822200","volume":"283","author":"JM Swiercz","year":"2008","unstructured":"Swiercz, J. M., Worzfeld, T. & Offermanns, S. ErbB-2 and met reciprocally regulate cellular signaling via plexin-B1. J. Biol. Chem. 283, 1893\u20131901 (2008).","journal-title":"J. Biol. Chem."},{"key":"58074_CR48","doi-asserted-by":"crossref","unstructured":"Akoumianakis, I., Polkinghorne, M. & Antoniades, C. Non-canonical WNT signalling in cardiovascular disease: mechanisms and therapeutic implications. Nat. Rev. Cardiol. 783\u2013797 (2022).","DOI":"10.1038\/s41569-022-00718-5"},{"key":"58074_CR49","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.str.2020.04.014","volume":"28","author":"S Cheng","year":"2020","unstructured":"Cheng, S. & \u00d6zkan, E. Finally on track: Interactions of off-track with plex-sema pathway and glycosaminoglycans. Structure 28, 492\u2013494 (2020).","journal-title":"Structure"},{"key":"58074_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2020.154986","volume":"127","author":"J Strickland","year":"2020","unstructured":"Strickland, J., Garrison, D. & Copple, B. L. Hypoxia upregulates Cxcl12 in hepatocytes by a complex mechanism involving hypoxia-inducible factors and transforming growth factor-\u03b2. Cytokine 127, 154986 (2020).","journal-title":"Cytokine"},{"key":"58074_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02952-1","volume":"20","author":"YH Chang","year":"2023","unstructured":"Chang, Y. H. et al. Protective role of IL-17-producing \u03b3\u03b4 T cells in a laser-induced choroidal neovascularization mouse model. J. Neuroinflammation 20, 279 (2023).","journal-title":"J. Neuroinflammation"},{"key":"58074_CR52","doi-asserted-by":"publisher","first-page":"7463","DOI":"10.1158\/0008-5472.CAN-11-2449","volume":"71","author":"N Obermajer","year":"2011","unstructured":"Obermajer, N., Muthuswamy, R., Odunsi, K., Edwards, R. P. & Kalinski, P. PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment. Cancer Res. 71, 7463\u20137470 (2011).","journal-title":"Cancer Res."},{"key":"58074_CR53","doi-asserted-by":"publisher","first-page":"919","DOI":"10.2174\/13894501113149990015","volume":"14","author":"RK Vadlapatla","year":"2013","unstructured":"Vadlapatla, R. K., Vadlapudi, A. D. & Mitra, A. K. Hypoxia-inducible factor-1 (HIF-1): a potential target for intervention in ocular neovascular diseases. Curr. Drug Targets 14, 919\u2013935 (2013).","journal-title":"Curr. Drug Targets"},{"key":"58074_CR54","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12964-022-00973-6","volume":"20","author":"P Zhan","year":"2022","unstructured":"Zhan, P. et al. PGE(2) promotes macrophage recruitment and neovascularization in murine wet-type AMD models. Cell Commun. Signal. 20, 155 (2022).","journal-title":"Cell Commun. Signal."},{"key":"58074_CR55","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1159\/000484907","volume":"44","author":"J Chen","year":"2017","unstructured":"Chen, J., Wang, W. & Li, Q. Increased Th1\/Th17 responses contribute to low-grade inflammation in age-related macular degeneration. Cellular Physiol. Biochem. 44, 357\u2013367 (2017).","journal-title":"Cellular Physiol. Biochem."},{"key":"58074_CR56","first-page":"158","volume":"1815","author":"RY Huang","year":"2011","unstructured":"Huang, R. Y. & Chen, G. G. Cigarette smoking, cyclooxygenase-2 pathway and cancer. Biochim. Biophys. Acta 1815, 158\u2013169 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"58074_CR57","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.7150\/ijbs.82317","volume":"19","author":"Y Yang","year":"2023","unstructured":"Yang, Y. et al. CXCL12-CXCR4\/CXCR7 Axis in Cancer: From mechanisms to clinical applications. Int. J. Biol. Sci. 19, 3341\u20133359 (2023).","journal-title":"Int. J. Biol. Sci."},{"key":"58074_CR58","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/31261","volume":"393","author":"K Tachibana","year":"1998","unstructured":"Tachibana, K. et al. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 393, 591\u2013594 (1998).","journal-title":"Nature"},{"key":"58074_CR59","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1096\/fj.06-7359com","volume":"21","author":"R Lima e Silva","year":"2007","unstructured":"Lima e Silva, R. et al. The SDF-1\/CXCR4 ligand\/receptor pair is an important contributor to several types of ocular neovascularization. FASEB J. 21, 3219\u20133230 (2007).","journal-title":"FASEB J."},{"key":"58074_CR60","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3109\/02713683.2011.593107","volume":"36","author":"ZX Zhang","year":"2011","unstructured":"Zhang, Z. X. et al. Hypoxia specific SDF-1 expression by retinal pigment epithelium initiates bone marrow-derived cells to participate in Choroidal neovascularization in a laser-induced mouse model. Curr. Eye Res. 36, 838\u2013849 (2011).","journal-title":"Curr. Eye Res."},{"key":"58074_CR61","doi-asserted-by":"publisher","first-page":"e0229342","DOI":"10.1371\/journal.pone.0229342","volume":"15","author":"Y Arai","year":"2020","unstructured":"Arai, Y. et al. Aqueous humour proteins and treatment outcomes of anti-VEGF therapy in neovascular age-related macular degeneration. PloS ONE 15, e0229342 (2020).","journal-title":"PloS ONE"},{"key":"58074_CR62","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10144","volume":"473","author":"P Carmeliet","year":"2011","unstructured":"Carmeliet, P. & Jain, R. K. Molecular mechanisms and clinical applications of angiogenesis. Nature 473, 298\u2013307 (2011).","journal-title":"Nature"},{"key":"58074_CR63","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nrc2442","volume":"8","author":"G Bergers","year":"2008","unstructured":"Bergers, G. & Hanahan, D. Modes of resistance to anti-angiogenic therapy. Nat. Rev. Cancer 8, 592\u2013603 (2008).","journal-title":"Nat. Rev. Cancer"},{"key":"58074_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9792","volume":"6","author":"A Mitsuhashi","year":"2015","unstructured":"Mitsuhashi, A. et al. Fibrocyte-like cells mediate acquired resistance to anti-angiogenic therapy with bevacizumab. Nat. Commun. 6, 8792 (2015).","journal-title":"Nat. Commun."},{"key":"58074_CR65","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.ccell.2020.05.005","volume":"37","author":"Y Shen","year":"2020","unstructured":"Shen, Y. et al. Reduction of liver metastasis stiffness improves response to bevacizumab in metastatic colorectal Cancer. Cancer cell 37, 800\u2013817 (2020).","journal-title":"Cancer cell"},{"key":"58074_CR66","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/cr.2011.198","volume":"22","author":"A Sakurai","year":"2012","unstructured":"Sakurai, A., Doci, C. L. & Gutkind, J. S. Semaphorin signaling in angiogenesis, lymphangiogenesis and cancer. Cell Res. 22, 23\u201332 (2012).","journal-title":"Cell Res."},{"key":"58074_CR67","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.15252\/emmm.201404922","volume":"7","author":"WJ Yang","year":"2015","unstructured":"Yang, W. J. et al. Semaphorin-3C signals through Neuropilin-1 and PlexinD1 receptors to inhibit pathological angiogenesis. EMBO Mol. Med. 7, 1267\u20131284 (2015).","journal-title":"EMBO Mol. Med."},{"key":"58074_CR68","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ebiom.2017.03.026","volume":"18","author":"Y Sun","year":"2017","unstructured":"Sun, Y. et al. Sema3f protects against subretinal neovascularization in vivo. EBioMedicine 18, 281\u2013287 (2017).","journal-title":"EBioMedicine"},{"key":"58074_CR69","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.cmet.2013.09.003","volume":"18","author":"A Cerani","year":"2013","unstructured":"Cerani, A. et al. Neuron-derived semaphorin 3A is an early inducer of vascular permeability in diabetic retinopathy via neuropilin-1. Cell Metab. 18, 505\u2013518 (2013).","journal-title":"Cell Metab."},{"key":"58074_CR70","doi-asserted-by":"publisher","first-page":"6024","DOI":"10.1182\/blood-2010-10-311589","volume":"117","author":"JS Joyal","year":"2011","unstructured":"Joyal, J. S. et al. Ischemic neurons prevent vascular regeneration of neural tissue by secreting semaphorin 3A. Blood 117, 6024\u20136035 (2011).","journal-title":"Blood"},{"key":"58074_CR71","doi-asserted-by":"publisher","first-page":"E6927","DOI":"10.1073\/pnas.1512683112","volume":"112","author":"Y Wei","year":"2015","unstructured":"Wei, Y. et al. Nrf2 in ischemic neurons promotes retinal vascular regeneration through regulation of semaphorin 6A. Proc. Natl. Acad. Sci. USA 112, E6927\u2013E6936 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"58074_CR72","doi-asserted-by":"publisher","unstructured":"Chen, D. Y. et al. Endothelium-derived semaphorin 3G attenuates ischemic retinopathy by coordinating beta-catenin-dependent vascular remodeling. J. Clin. Invest. 131, https:\/\/doi.org\/10.1172\/jci135296 (2021).","DOI":"10.1172\/jci135296"},{"key":"58074_CR73","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1172\/JCI44900","volume":"121","author":"Y Fukushima","year":"2011","unstructured":"Fukushima, Y. et al. Sema3E-PlexinD1 signaling selectively suppresses disoriented angiogenesis in ischemic retinopathy in mice. J. Clin. Invest. 121, 1974\u20131985 (2011).","journal-title":"J. Clin. Invest."},{"key":"58074_CR74","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201810154","volume":"12","author":"JH Wu","year":"2020","unstructured":"Wu, J. H. et al. Inhibition of Sema4D\/PlexinB1 signaling alleviates vascular dysfunction in diabetic retinopathy. EMBO Mol. Med. 12, e10154 (2020).","journal-title":"EMBO Mol. Med."},{"key":"58074_CR75","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/bjd\/ljae205","volume":"191","author":"C Dong","year":"2024","unstructured":"Dong, C. et al. Fibroblasts with high matrix metalloproteinase 2 expression regulate CD8+ T-cell residency and inflammation via CD100 in psoriasis. Br.J. Dermatol. 191, 405\u2013418 (2024).","journal-title":"Br.J. Dermatol."},{"key":"58074_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106886","volume":"195","author":"L Wang","year":"2023","unstructured":"Wang, L. et al. Knockout of Sema4D alleviates liver fibrosis by suppressing AOX1 expression. Pharmacol. Res. 195, 106886 (2023).","journal-title":"Pharmacol. Res."},{"key":"58074_CR77","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1080\/19420862.2015.1102813","volume":"8","author":"TL Fisher","year":"2016","unstructured":"Fisher, T. L. et al. Generation and preclinical characterization of an antibody specific for SEMA4D. mAbs 8, 150\u2013162 (2016).","journal-title":"mAbs"},{"key":"58074_CR78","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1038\/s41591-022-01919-8","volume":"28","author":"A Feigin","year":"2022","unstructured":"Feigin, A. et al. Pepinemab antibody blockade of SEMA4D in early Huntington\u2019s disease: a randomized, placebo-controlled, phase 2 trial. Nat. Med. 28, 2183\u20132193 (2022).","journal-title":"Nat. Med."},{"key":"58074_CR79","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1158\/1078-0432.CCR-15-0431","volume":"22","author":"A Patnaik","year":"2016","unstructured":"Patnaik, A. et al. Safety, pharmacokinetics, and pharmacodynamics of a humanized anti-semaphorin 4D antibody, in a first-in-human study of patients with advanced solid tumors. Clin. Cancer Res. 22, 827\u2013836 (2016).","journal-title":"Clin. Cancer Res."},{"key":"58074_CR80","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000367","volume":"4","author":"C LaGanke","year":"2017","unstructured":"LaGanke, C. et al. Safety\/tolerability of the anti-semaphorin 4D Antibody VX15\/2503 in a randomized phase 1 trial. Neurol. Neuroimmunol. Neuroinflamm. 4, e367 (2017).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"58074_CR81","doi-asserted-by":"publisher","first-page":"3630","DOI":"10.1158\/1078-0432.CCR-20-4792","volume":"27","author":"MR Shafique","year":"2021","unstructured":"Shafique, M. R. et al. A phase Ib\/II study of pepinemab in combination with avelumab in advanced non-small cell lung cancer. Clin. Cancer Res. 27, 3630\u20133640 (2021).","journal-title":"Clin. Cancer Res."},{"key":"58074_CR82","doi-asserted-by":"publisher","first-page":"4320","DOI":"10.1007\/s12035-017-0649-5","volume":"55","author":"A Bulloj","year":"2018","unstructured":"Bulloj, A., Maminishkis, A., Mizui, M. & Finnemann, S. C. Semaphorin4D-PlexinB1 signaling attenuates photoreceptor outer segment phagocytosis by reducing Rac1 activity of RPE cells. Mol. Neurobiol. 55, 4320\u20134332 (2018).","journal-title":"Mol. Neurobiol."},{"key":"58074_CR83","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1248\/bpb.b12-00407","volume":"35","author":"Y Li","year":"2012","unstructured":"Li, Y. et al. A rat model for stable chronic obstructive pulmonary disease induced by cigarette smoke inhalation and repetitive bacterial infection. Biol. Pharm. Bull. 35, 1752\u20131760 (2012).","journal-title":"Biol. Pharm. Bull."},{"key":"58074_CR84","doi-asserted-by":"publisher","unstructured":"Liu, S. et al. An optimized procedure to record visual evoked potential in mice. Exp. Eye Res. 218, https:\/\/doi.org\/10.1016\/j.exer.2022.109011 (2022).","DOI":"10.1016\/j.exer.2022.109011"},{"key":"58074_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155584","volume":"144","author":"B Cui","year":"2023","unstructured":"Cui, B. et al. Exercise alleviates neovascular age-related macular degeneration by inhibiting AIM2 inflammasome in myeloid cells. Metab. Clin. Exp. 144, 155584 (2023).","journal-title":"Metab. Clin. Exp."},{"key":"58074_CR86","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1089\/jop.2016.0153","volume":"33","author":"J Guo","year":"2017","unstructured":"Guo, J., Luo, X., Liang, J., Xiao, M. & Sun, X. Antiangiogenic effects of doxazosin on experimental choroidal neovascularization in mice. J. Ocular Pharmacol. Ther. 33, 50\u201356 (2017).","journal-title":"J. Ocular Pharmacol. Ther."},{"key":"58074_CR87","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1089\/jop.2014.0023","volume":"31","author":"CR Rho","year":"2015","unstructured":"Rho, C. R. et al. Antiangiogenic effects of topically administered multiple kinase inhibitor, motesanib (AMG 706), on experimental choroidal neovascularization in mice. J. Ocular Pharmacol. Ther. 31, 25\u201331 (2015).","journal-title":"J. Ocular Pharmacol. Ther."},{"key":"58074_CR88","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"58074_CR89","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1093\/bioinformatics\/bty890","volume":"35","author":"A Jain","year":"2019","unstructured":"Jain, A. & Tuteja, G. TissueEnrich: Tissue-specific gene enrichment analysis. Bioinformatics 35, 1966\u20131967 (2019).","journal-title":"Bioinformatics"},{"key":"58074_CR90","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"58074_CR91","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"58074_CR92","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon, A. et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics 27, 1739\u20131740 (2011).","journal-title":"Bioinformatics"},{"key":"58074_CR93","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.cell.2015.05.002","volume":"161","author":"EZ Macosko","year":"2015","unstructured":"Macosko, E. Z. et al. Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets. Cell 161, 1202\u20131214 (2015).","journal-title":"Cell"},{"key":"58074_CR94","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411\u2013420 (2018).","journal-title":"Nat. Biotechnol."},{"key":"58074_CR95","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41586-018-0414-6","volume":"560","author":"G La Manno","year":"2018","unstructured":"La Manno, G. et al. RNA velocity of single cells. Nature 560, 494\u2013498 (2018).","journal-title":"Nature"},{"key":"58074_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin, S. et al. Inference and analysis of cell-cell communication using CellChat. Nat. Commun. 12, 1088 (2021).","journal-title":"Nat. Commun."},{"key":"58074_CR97","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.abj8393","volume":"14","author":"Y Shen","year":"2021","unstructured":"Shen, Y. et al. STAT3-YAP\/TAZ signaling in endothelial cells promotes tumor angiogenesis. Sci. Signal 14, eabj8393 (2021).","journal-title":"Sci. Signal"},{"key":"58074_CR98","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41421-021-00360-4","volume":"7","author":"J Liu","year":"2021","unstructured":"Liu, J. et al. Heterologous prime-boost immunizations with chimpanzee adenoviral vectors elicit potent and protective immunity against SARS-CoV-2 infection. Cell Discov. 7, 123 (2021).","journal-title":"Cell Discov."},{"key":"58074_CR99","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1039\/c3lc41320a","volume":"13","author":"S Kim","year":"2013","unstructured":"Kim, S., Lee, H., Chung, M. & Jeon, N. L. Engineering of functional, perfusable 3D microvascular networks on a chip. Lab on a Chip 13, 1489\u20131500 (2013).","journal-title":"Lab on a Chip"},{"key":"58074_CR100","doi-asserted-by":"publisher","unstructured":"He, H. et al. Activating NO-sGC crosstalk in the mouse vascular niche promotes vascular integrity and mitigates acute lung injury. J. Exp. Med. 220, https:\/\/doi.org\/10.1084\/jem.20211422 (2023).","DOI":"10.1084\/jem.20211422"},{"key":"58074_CR101","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1016\/j.ajpath.2011.01.013","volume":"178","author":"S Lavalette","year":"2011","unstructured":"Lavalette, S. et al. Interleukin-1beta inhibition prevents choroidal neovascularization and does not exacerbate photoreceptor degeneration. Am. J. Pathol. 178, 2416\u20132423 (2011).","journal-title":"Am. J. Pathol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58074-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58074-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58074-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T21:42:43Z","timestamp":1742852563000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58074-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,22]]},"references-count":101,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["58074"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-58074-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,22]]},"assertion":[{"value":"18 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2821"}}